Also known as: Eurofins Scientific
Eurofins Scientific is a global leader in food, environmental, pharmaceutical, cosmetic, genomics, and clinical diagnostic testing services. The group operates a decentralized network of laboratories and provides analytical methods, clinical diagnostics, and bioPharma contract services worldwide.
The large molecule drug substance CDMO market is expected to grow at approximately 9% CAGR through 2031, driven by rising demand for biologics and biosimilars, streamlined regulatory approval pathways, and increasing FDA and EMA approvals for biologic therapies.
The global drug discovery services market is valued at $22.04 billion in 2025 and is forecast to reach $75.13 billion by 2034, growing at a 14.6% CAGR from 2026-2034, driven by rising industry demand and technological advancements.
